NEONC TECHNOLOGIES HOLDINGS, INC. Operating Cash Flow
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) reported Operating Cash Flow of -$11.76 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-10
- NEONC TECHNOLOGIES HOLDINGS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$4.77M.
- NEONC TECHNOLOGIES HOLDINGS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$6.99M.
- NEONC TECHNOLOGIES HOLDINGS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$3.59M.
- NEONC TECHNOLOGIES HOLDINGS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$5.81M.
- NEONC TECHNOLOGIES HOLDINGS, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$20.36M.
- NEONC TECHNOLOGIES HOLDINGS, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$4.21M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$4.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$11.76M 10-Q · filed 2026-08-10 | -$15.35M derived: sum of 3 quarters · filed 2026-08-10 | -$21.16M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | -$6.99M 10-Q · filed 2026-05-15 | -$10.58M derived: sum of 2 quarters · filed 2026-05-15 | -$16.39M derived: sum of 3 quarters · filed 2026-05-15 | -$21.71M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | -$3.59M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$9.40M derived: sum of 2 quarters · filed 2026-03-31 | -$14.71M derived: sum of 3 quarters · filed 2026-08-10 | -$20.36M 10-K · filed 2026-03-31 |
| 2025-09-30 | -$5.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$11.12M derived: sum of 2 quarters · filed 2026-08-10 | -$16.77M 10-Q · filed 2025-11-14 | -$17.73M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | -$5.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$10.96M 10-Q · filed 2026-08-10 | -$11.92M derived: sum of 3 quarters · filed 2026-08-10 | -$15.01M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | -$5.65M 10-Q · filed 2026-05-15 | -$6.60M derived: sum of 2 quarters · filed 2026-05-15 | -$9.69M derived: sum of 3 quarters · filed 2026-05-15 | -$10.01M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | -$954.40K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$4.04M derived: sum of 2 quarters · filed 2026-03-31 | -$4.36M derived: sum of 3 quarters · filed 2026-03-31 | -$4.21M 10-K · filed 2026-03-31 |
| 2024-09-30 | -$3.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$3.41M derived: sum of 2 quarters · filed 2025-11-14 | -$3.26M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | -$318.20K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-18 | -$172.46K 10-Q · filed 2025-08-18 | ||
| 2024-03-31 | $145.75K 10-Q · filed 2025-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |